Citigroup Portfolio holdings
Citigroup is a multinational investment bank and financial services company, formed in 1998 when Citicorp, the holding company for Citibank, merged with Travelers. Citibank dates to 1812, when it was chartered as City Bank of New York to serve a group of local merchants. In 2009 it merged its Smith Barney brokerage and wealth unit with Morgan Stanley's into a joint venture, and in 2013 it sold its remaining stake to Morgan Stanley. Its businesses cover investment, corporate and commercial banking, sales and trading in the markets, cash management and trade finance for companies, wealth management, and credit cards in the United States.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.36B |
| 2 |
Tesla
TSLA
|
+$1.09B |
| 3 |
Amazon
AMZN
|
+$1B |
| 4 |
Microsoft
MSFT
|
+$963M |
| 5 |
Apple
AAPL
|
+$864M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.22B |
| 2 |
Bank of America
BAC
|
+$1.2B |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$381M |
| 4 |
First Trust Dow Jones Internet Index Fund ETF
FDN
|
+$294M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.44% |
| 2 | Technology | 25.75% |
| 3 | Financials | 6.27% |
| 4 | Consumer Discretionary | 5.79% |
| 5 | Industrials | 5.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3776
Costamare Bulkers Holdings
CMDB
$446M
| $526K | ﹤0.01% |
29,958
+15,460
| +107% | +$269K |
2025 Q2
4 quarters
|
|
3777
Rithm Acquisition Corp
RAC
$311M
| $523K | ﹤0.01% |
50,000
-18,207
| -27% | -$190K |
2025 Q4
2 quarters
|
|
3778
DELISTED
Clear Channel Outdoor Holdings
CCO
| $522K | ﹤0.01% |
215,700
+207,127
| +2,416% | +$496K |
2013 Q2
52 quarters
|
|
3779
Janus Living Inc
JAN
$6.94B
| $522K | ﹤0.01% |
+18,158
| New | +$471K |
2026 Q2
0 quarters
|
|
3780
Southern California Bancorp
BCAL
$696M
| $522K | ﹤0.01% |
25,024
+1,163
| +5% | +$22.1K |
2023 Q4
10 quarters
|
|
3781
CorMedix
CRMD
$433M
| $520K | ﹤0.01% |
66,228
+28,077
| +74% | +$222K |
2023 Q2
12 quarters
|
|
3782
Structure Therapeutics
GPCR
$1.45B
| $520K | ﹤0.01% |
9,680
-10,814
| -53% | -$478K |
2023 Q3
11 quarters
|
|
3783
CALL
StubHub Holdings
STUB
$2.32B
| $517K | ﹤0.01% |
+40,200
| New | +$355K |
2026 Q2
0 quarters
|
|
3784
Generate Biomedicines
GENB
$1.78B
| $516K | ﹤0.01% |
30,587
+28,343
| +1,263% | +$386K |
2026 Q1
1 quarter
|
|
3785
Ovid Therapeutics
OVID
$469M
| $514K | ﹤0.01% |
191,058
+76,816
| +67% | +$198K |
2023 Q2
12 quarters
|
|
3786
Weibo
WB
$1.55B
| $513K | ﹤0.01% |
70,719
+1,356
| +2% | +$11.1K |
2014 Q2
48 quarters
|
|
3787
iShares Ethereum Trust ETF
ETHA
$7.23B
| $512K | ﹤0.01% |
+14,351
| New | +$668K |
2026 Q2
0 quarters
|
|
3788
Scholastic
SCHL
$701M
| $511K | ﹤0.01% |
11,114
+4,736
| +74% | +$194K |
2013 Q2
52 quarters
|
|
3789
Civista Bancshares
CIVB
$590M
| $511K | ﹤0.01% |
18,111
+12,958
| +251% | +$329K |
2023 Q2
12 quarters
|
|
3790
Winnebago Industries
WGO
$898M
| $510K | ﹤0.01% |
16,332
-6,005
| -27% | -$183K |
2013 Q2
52 quarters
|
|
3791
LB Pharmaceuticals
LBRX
$1.3B
| $510K | ﹤0.01% |
15,719
+10,150
| +182% | +$298K |
2025 Q4
2 quarters
|
|
3792
DELISTED
Northfield Bancorp
NFBK
| $510K | ﹤0.01% |
34,623
+17,091
| +97% | +$242K |
2013 Q2
52 quarters
|
|
3793
Utz Brands
UTZ
$1.27B
| $510K | ﹤0.01% |
66,225
+60,242
| +1,007% | +$449K |
2020 Q4
22 quarters
|
|
3794
Schwab US Large-Cap Value ETF
SCHV
$15.7B
| $510K | ﹤0.01% |
14,637
-1,483
| -9% | -$48.9K |
2021 Q2
20 quarters
|
|
3795
CALL
Vir Biotechnology
VIR
$1.9B
| $510K | ﹤0.01% |
+50,000
| New | +$476K |
2026 Q2
0 quarters
|
|
|
3796
PUT
Vir Biotechnology
VIR
$1.9B
| $510K | ﹤0.01% |
+50,000
| New | +$476K |
2026 Q2
0 quarters
|
|
3797
Saul Centers
BFS
$709M
| $507K | ﹤0.01% |
13,552
+4,831
| +55% | +$169K |
2013 Q2
52 quarters
|
|
3798
iShares TLT Premium Income+ ETF
TLTW
$1.58B
| $505K | ﹤0.01% |
22,623
+18,638
| +468% | +$415K |
2026 Q1
1 quarter
|
|
3799
Vanda Pharmaceuticals
VNDA
$227M
| $503K | ﹤0.01% |
82,173
-6,991
| -8% | -$45.7K |
2013 Q2
52 quarters
|
|
3800
Matthews International
MATW
$613M
| $503K | ﹤0.01% |
18,681
+10,825
| +138% | +$291K |
2013 Q2
52 quarters
|
|
Similar funds
Citigroup's Q2 2026 Portfolio in Review
As of Q2 2026, Citigroup held 6,442 positions worth $303B, up 29% from $235B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup deployed $27.6B of net new capital in Q2 2026, opening 555 new positions and adding to 3,283 existing holdings. Its largest new stake was Honeywell Aerospace: 579,875 shares worth $128M.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, down from 45% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $1.22B trimmed.
- Citigroup's largest Q2 2026 buy was Honeywell Aerospace: 579,875 shares worth $128M.
- Citigroup added most to NVIDIA in Q2 2026, an estimated $2.36B increase.
- Citigroup's biggest Q2 2026 reduction was iShares Russell 2000 ETF, cutting an estimated $1.22B.
- Citigroup fully exited Sealed Air in Q2 2026, selling an estimated $111M.
- Citigroup's ten largest holdings make up 20% of its $303B portfolio in Q2 2026.
- Citigroup opened 555 new positions and closed 760 in Q2 2026.
- Citigroup's portfolio value rose 29% quarter-over-quarter to $303B.
Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.